Applied Pharmaceutical Toxicology (APT) 2024

APPLIED PHARMACEUTICAL TOXICOLOGY (APT) 2024
The Boston Society is a non-profit organization founded in 2004 as an organization that promotes education, training, discussion, and scientific events in support of drug discovery, development, and related topics. 

Medicilon is excited to attend and exhibit at the conference. Dr. Qingcong Lin, president of Medicilon USA Corp. will give a presentation "Preclinical Safety Evaluation for Antibody Drug Conjugates (ADCs)" at 1:25-1:35 local time on May 14^th, we sincerely invite you to visit us at Booth #3! Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. 

Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.

As of April 2024, Medicilon has proudly served over 2000 clients worldwide, contributing to the successful approval of over 400 IND applications in China and over 70 INDs overseas, demonstrating our commitment to providing high-quality services and supporting the global advancement of pharmaceutical development.

Date: May 14-16, 2024
Location:  Merck Research Laboratories, Boston, MA
Medicilon Booth #3

Meet with Medicilon

Subject丨APPLIED PHARMACEUTICAL TOXICOLOGY (APT) 2024

Company *

Name *

Work Email *

Title*

Verification Code